Ministry of Health announcement on the cost of subsidized patients in Cyprus and drugs approved by the Nominal Claims Committee
The Ministry of Health's demand that the OAI include in its budget for 2023, an allocation of 123 million euros to cover the Ministry's expenses for sending patients to non-GESH hospitals in Cyprus, referrals of patients abroad and drugs available through the Nominal Requests Committee, the Ministry positioned itself through an official statement. ]
As a reminder, in his statements this morning, the Health Minister himself also took a position on the issue stating, among other things, that "the aim is to serve patients and find solutions where solutions cannot be provided by the GESY at this particular time".
The Ministry of Health clarifies the following:
- The Ministry of Health, in proposals submitted to the Ministry of Finance for the 2023 budget, included provisions of 18 million euros for the 2023 budget. 18 million for subsidised patients in the private sector in Cyprus, 25 million for patient missions abroad and 80 million for medicines approved by the Nominal Claims Committee (NCC). These amounts are an estimate based on actual expenditure in previous years for budgeting purposes.
- In five letters to the President of the Health Insurance Agency, the Ministry of Health enclosed lists of drugs for which claims had been submitted to the Nominal Claims Committee and repeatedly requested the evaluation of these drugs for inclusion in the lists reimbursed by the Health Insurance Agency.
- The Names Claims Committee (NCC) is responsible for reviewing requests for names for the administration of drugs that are not included in the list of drugs reimbursed by the Health Insurance Agency or that are included in that list and are outside the terms and conditions set by the HHA. In accordance with the established procedure, the doctor applies for the administration of the above-mentioned medicines to the EDA committee, which is composed of four doctors and three pharmacists, and each request is examined individually.
- It should be noted that, at present, new innovative medicines and new revised pharmacotherapies covering the whole range of conditions such as cancer, haematological, neurological, pulmonological, psychiatric, rheumatological, antimicrobial, gene therapy, chronic and/or rare diseases, etc. are provided to Cypriot citizens only through the approval of the requests by the EEA.
- It is stressed that in the years 2016-2020 the approvals of the EIOs concerned only requests from doctors of the public hospitals, the Oncology Department of the Bank of Cyprus and the Institute of Neurology and Genetics for the eligible patients of the previous system (before the implementation of the YESY about 600 thousand beneficiaries).
- From 2021 onwards, EOA's approvals concern requests from all physicians contracted to the General Health Insurance Scheme (OKYPY, private hospitals, clinics, Bank of Cyprus Oncology, Institute of Neurology and Genetics, German Oncology Centre, Mediteranean Hospital, etc.).a.o.) for all eligible patients of the SHI (about 950 thousand beneficiaries).
- The expenditure of the EOA does not only concern the initiation of pharmacotherapies but also their continuation. That is to say, if the ERA approves the continuation of a patient's treatment for the following years, it is still covered by an ERA allocation. Therefore, the more patients are approved each year, the more the budget increases.
The Ministry of Health, after the implementation of the second phase of the GHS and in consultation with the OAI, refers patients to the private sector in Cyprus for services that cannot currently be handled under the GHS. In this regard, there is a relevant letter from An. In this regard, there is a relevant letter from the Director General of OAS to the Ministry of Health, requesting that these services be handled until they are included in the General Health System.
- All referrals, without exception, are made on the basis of statutory procedures and a positive opinion of the Specialist Medical Committees in accordance with the provisions of the Financial Assistance Plan, which are followed by the Ministry of Health.
- All referrals are handled by the Ministry of Health, either abroad or at home, in order to safeguard public health and avoid endangering human lives, and concern categories of health services which have not yet been able to be included in the GHS. The referrals abroad concern complex and difficult cases which require a multidisciplinary team or specialised expertise and cannot be treated on the territory of the Republic of Cyprus.
It is emphasised that all procedures are subject to an annual audit by the Audit Office.
The Ministry of Health is committed to patient service and unhindered access to health services. Issues of health and human life do not lend themselves to frivolous judgments and petty political considerations.
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source